A detailed history of Simplex Trading, LLC transactions in Gh Research PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 25 shares of GHRS stock, worth $303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 17 47.06%
Holding current value
$303
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

BUY
$8.66 - $13.79 $69 - $110
8 Added 47.06%
25 $0
Q1 2025

May 12, 2025

BUY
$7.91 - $17.99 $134 - $305
17 New
17 $0
Q4 2023

Feb 02, 2024

BUY
$5.26 - $11.04 $520 - $1,092
99 New
99 $0

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $632M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.